CO6531487A2 - Proceso para la elaboración de compuestos orgánicos - Google Patents

Proceso para la elaboración de compuestos orgánicos

Info

Publication number
CO6531487A2
CO6531487A2 CO12068973A CO12068973A CO6531487A2 CO 6531487 A2 CO6531487 A2 CO 6531487A2 CO 12068973 A CO12068973 A CO 12068973A CO 12068973 A CO12068973 A CO 12068973A CO 6531487 A2 CO6531487 A2 CO 6531487A2
Authority
CO
Colombia
Prior art keywords
elaboration
organic compounds
angiotensin
receptor antagonist
receptor
Prior art date
Application number
CO12068973A
Other languages
English (en)
Inventor
Gottfried Sedelmeier
Florian Andreas Rampf
Dominique Grimler
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41716392&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6531487(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CO6531487A2 publication Critical patent/CO6531487A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/32—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/32—Separation; Purification; Stabilisation; Use of additives
    • C07C253/34—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/50—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a procesos para la elaboración de un bloqueador de los receptores de angiotensina (ARB; también denominado como antagonista de los receptores de angiotensina II o antagonista del receptor AT1), y a sales de los mismos, a intermediarios novedosos, y a los pasos del proceso.
CO12068973A 2009-10-27 2012-04-26 Proceso para la elaboración de compuestos orgánicos CO6531487A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09174264A EP2316821A1 (en) 2009-10-27 2009-10-27 Process for the manufacture of organic compounds

Publications (1)

Publication Number Publication Date
CO6531487A2 true CO6531487A2 (es) 2012-09-28

Family

ID=41716392

Family Applications (1)

Application Number Title Priority Date Filing Date
CO12068973A CO6531487A2 (es) 2009-10-27 2012-04-26 Proceso para la elaboración de compuestos orgánicos

Country Status (23)

Country Link
US (1) US20120238761A1 (es)
EP (2) EP2316821A1 (es)
JP (1) JP2013508436A (es)
KR (1) KR20120098652A (es)
CN (1) CN102596899A (es)
AR (1) AR079104A1 (es)
AU (1) AU2010311636B2 (es)
BR (1) BR112012009815A2 (es)
CA (1) CA2777031A1 (es)
CL (1) CL2012001081A1 (es)
CO (1) CO6531487A2 (es)
EC (1) ECSP12011833A (es)
IL (1) IL219111A0 (es)
IN (1) IN2012DN03032A (es)
MA (1) MA33692B1 (es)
MX (1) MX2012005025A (es)
NZ (1) NZ599218A (es)
PE (1) PE20121501A1 (es)
RU (1) RU2012121591A (es)
TN (1) TN2012000154A1 (es)
TW (1) TW201124389A (es)
WO (1) WO2011051213A1 (es)
ZA (1) ZA201202490B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102321038B (zh) * 2011-07-11 2014-03-26 安徽省虹升生物科技有限公司 一种改进的制备缬沙坦方法
FR2981077B1 (fr) * 2011-10-11 2013-11-01 Michelin Soc Tech Methode pour preparer un melange maitre d'elastomere dienique et de silice
US10745363B2 (en) 2016-09-02 2020-08-18 Nanjing Noratech Pharmaceuticals Co., Ltd Crystal forms of valsartan disodium salt
CN110078640B (zh) * 2019-03-29 2022-04-05 浙江美诺华药物化学有限公司 一种缬沙坦中间体的合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874867A (en) 1987-05-22 1989-10-17 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
DK0443983T3 (da) 1990-02-19 1996-03-18 Ciba Geigy Ag Acrylforbindelser
JPH04297466A (ja) 1990-06-22 1992-10-21 Nippon Shinyaku Co Ltd テトラゾール誘導体及び医薬
GB9222700D0 (en) * 1992-10-29 1992-12-09 Smithkline Beecham Plc Chemical compounds
GB0222056D0 (en) 2002-09-23 2002-10-30 Novartis Ag Process for the manufacture of organic compounds
GB0316546D0 (en) * 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds
ITMI20032267A1 (it) * 2003-11-21 2005-05-22 Dinamite Dipharma S P A In Forma A Bbreviata Diph Procdimento per la preparzione di valsartan e suoi intermedi
HRP20030965A2 (en) * 2003-11-24 2005-08-31 Belupo - Lijekovi I Kozmetika D.D. Process for production of (s)-n-pentanoyl-n-[[2'-(
EP1714963A1 (en) * 2005-04-19 2006-10-25 IPCA Laboratories Limited Process for the Preparation of Valsartan and its Intermediates
CA2619955A1 (en) * 2005-08-22 2007-03-22 Alembic Limited Process for preparing valsartan
WO2008004110A2 (en) * 2006-07-03 2008-01-10 Aurobindo Pharma Limited Process for the preparation of the angiotensin ii antagonist valsartan
CN101450917B (zh) * 2007-12-06 2012-07-11 浙江海正药业股份有限公司 缬沙坦的合成方法
US7943794B2 (en) * 2008-02-13 2011-05-17 Ranbaxy Laboratories Limited Processes for the preparation of intermediates of valsartan

Also Published As

Publication number Publication date
IN2012DN03032A (es) 2015-07-31
EP2493848A1 (en) 2012-09-05
CA2777031A1 (en) 2011-05-05
TW201124389A (en) 2011-07-16
IL219111A0 (en) 2012-06-28
KR20120098652A (ko) 2012-09-05
NZ599218A (en) 2014-02-28
EP2316821A1 (en) 2011-05-04
AR079104A1 (es) 2011-12-28
AU2010311636B2 (en) 2014-03-06
CN102596899A (zh) 2012-07-18
TN2012000154A1 (en) 2013-12-12
MA33692B1 (fr) 2012-10-01
PE20121501A1 (es) 2012-11-15
AU2010311636A1 (en) 2012-05-03
ZA201202490B (en) 2012-12-27
BR112012009815A2 (pt) 2016-10-18
JP2013508436A (ja) 2013-03-07
ECSP12011833A (es) 2012-06-29
US20120238761A1 (en) 2012-09-20
RU2012121591A (ru) 2013-12-10
WO2011051213A1 (en) 2011-05-05
CL2012001081A1 (es) 2013-06-14
MX2012005025A (es) 2012-06-08

Similar Documents

Publication Publication Date Title
BR112014019909A8 (pt) Processo para produção de compostos úteis como antagonistas do receptor de orexina-2
UY38712A (es) Lactamas fusionadas de arilo y heteroarilo
CR20130087A (es) Compuestos de espiropiperidina como antagonistas del receptor orl-1
CR20150370A (es) Compuestos antivirales
CR20140229A (es) Nuevos derivados bicíclicos de dihidroisoquinolin-1-ona
ECSP13012612A (es) Derivados de quinazolin-4-(3h)-ona utilizados como inhibidores de p13 cinasa
UY34202A (es) Compuestos fungicidas 2-(2-clor0-4-(4-cloro-fenoxi)-fenil]-1-(1,2,4]triazol-1-1l-etanol alquilo sustituidos
CR11751A (es) Hidroximetil pirrolidinas como agonistas del receptor adrenergico beta3
UY32640A (es) Aril-pirimidinas como inhibidoras de sintasa dfe aldosterona
EA201491305A1 (ru) Конденсированные трициклические соединения в качестве ингибиторов raf киназы
ECSP11011288A (es) Derivados de indol como antagonistas del receptor crth2
UY32574A (es) Antagonistas del receptor cxcr3
ES2657549T3 (es) Piridopirazinas sustituidas como nuevos inhibidores de SYK
CL2013003686A1 (es) Compuestos derivados de ergolina, antagonista del receptor de 5-ht1d; útiles para el tratamiento de la migraña.
EA201491303A1 (ru) Конденсированные тетра- или пентациклические дигидродиазепинокарбазолоны в качестве ингибиторов parps
CL2012002082A1 (es) Proceso para la preparacion de lacosamida, por hidroximetilación; compuestos intermediarios.
BR112013016241A2 (pt) composto, e, método para fabricar um composto
UY34329A (es) Compuestos de triazolopiridina
UY34629A (es) Inhibidores de pirazolopirimidinilo de enzima activadora de ubicuitina
NI201000233A (es) Proceso para la preparación de derivados de pirimidina benzoimidazol - 2 - il.
CR20150267A (es) 6-((s)-1-{1-[5-(2-hidroxi-etoxi)-piridin-2-il] 1h-pirazol-3-il}-etil)-3h-1,3-benzotiazol-2-ona como un antagonista del receptor ampa dependiente de tarp-gamma 8
CR20130625A (es) Derivados de la piperidina 3-espirocíclica como agonistas de receptores de la ghrelina
DK2606042T3 (da) Disubstituerede tetrahydrofuranyl-forbindelser som antagonister af bradykinin-b1-receptor
ECSP13013016A (es) Derivados de 2-amino-3-(imidazol-2-il)-piridin-4-ona, y su uso como inhibidores de la cinasa del receptor vegf
ECSP12011833A (es) Proceso para la elaboración de compuestos orgánicos